It was a complicated process of curation and unfortunately we did not keep track of all the changes. However, you can easily identify those samples thanks to the "series" slot in the phenodata: NKI and NKI2 stand for the first and second papers respectively. We removed samples from the first series in priority.

I hope this helps.
---
Benjamin Haibe-Kains
Computational Biology and Functional Genomics Laboratory
Center for Cancer Computational Biology
Harvard School of Public Health, Dana-Farber Cancer Institute (SM824)

Phone: +1 (617) 582 7267
Fax:   +1 (617) 582 7760
Email: bhaibeka@jimmy.harvard.edu
Webpage: http://www.hsph.harvard.edu/research/benjamin-haibe-kains/

On Oct 25, 2011, at 11:51 AM, Xavier Robin wrote:

> Le 25. 10. 11 13:59, Markus Schroeder a écrit :
>> On 10/25/2011 12:47 PM, Sean Davis wrote:
>>> There was overlap between the van't Veer and van de Vijver datasets,
>>> so the numbers are for unique patients only, I believe.
>> 
>> Yes, the duplicate patients were removed which resulted in 337 unique
>> patients for both studies.
> 
> Thank you Sean and Markus for your answers.
> 
> Do you know which are these duplicate patients?
> 
> Thanks again,
> Xavier


	[[alternative HTML version deleted]]

